Literature DB >> 14295780

THE EFFECT OF PORTACAVAL TRANSPOSITION ON CARBOHYDRATE METABOLISM: EXPERIMENTAL AND CLINICAL OBSERVATIONS.

T E STARZL, T L MARCHIORO, A W SEXTON, B ILLINGWORTH, W R WADDELL, T D FARIS, T J HERRMANN.   

Abstract

Entities:  

Keywords:  CARBOHYDRATE METABOLISM; CHILD; DOGS; GLUCOSE TOLERANCE TEST; GLUCOSEPHOSPHATASE; GLUCOSIDASE; GLYCOGENOSIS; LIVER CIRRHOSIS; LIVER ENZYMOLOGY; LIVER GLYCOGEN; PHOSPHOTRANSFERASES; PORTACAVAL ANASTOMOSIS; PORTACAVAL TRANSPOSITION

Mesh：

Substances：

Year:  1965        PMID： 14295780      PMCID： PMC2994194     

Source DB:  PubMed          Journal:  Surgery        ISSN： 0039-6060            Impact factor:   3.982


× No keyword cloud information.
  25 in total

1.  Type IV glycogenosis. Report of a case proven by characterization of glycogen and studied at necropsy.

Authors:  J B SIDBURY; J MASON; W B BURNS; B H RUEBNER
Journal:  Bull Johns Hopkins Hosp       Date:  1962-09

2.  Studies on the site of origin of the agent causing hypersecretion in dogs with portacaval shunt.

Authors:  J S CLARKE; P K McKISSOCK; K CRUZE
Journal:  Surgery       Date:  1959-07       Impact factor: 3.982

3.  Amylo-1, 6-glucosidase in muscle tissue in generalized glycogen storage disease.

Authors:  B ILLINGWORTH; G T CORI; C F CORI
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

4.  Structure of glycogens and amylopectins. I. Enzymatic determination of chain length.

Authors:  B ILLINGWORTH; J LARNER; G T CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157

5.  A Technique for Portacaval Transposition.

Authors:  Thomas E Starzl; George W Butz; David H Munger
Journal:  J Surg Res       Date:  1961-09       Impact factor: 2.192

6.  A FUNCTIONAL DISORDER OF MUSCLE ASSOCIATED WITH THE ABSENCE OF PHOSPHORYLASE.

Authors:  W F Mommaerts; B Illingworth; C M Pearson; R J Guillory; K Seraydarian
Journal:  Proc Natl Acad Sci U S A       Date:  1959-06       Impact factor: 11.205

7.  Gaucher's Disease With Ascites: Response to Portacaval Shunt.

Authors:  A M Imparato
Journal:  Ann Surg       Date:  1960-03       Impact factor: 12.969

8.  Glycogen fractions of liver and muscle.

Authors:  W L BLOOM; G T LEWIS; M Z SCHUMPERT; T M SHEN
Journal:  J Biol Chem       Date:  1951-02       Impact factor: 5.157

9.  The estimation of glycogen with the anthrone reagent.

Authors:  S SEIFTER; S DAYTON
Journal:  Arch Biochem       Date:  1950-01

10.  Structure of glycogens and amylopectins. III. Normal and abnormal human glycogen.

Authors:  B ILLINGWORTH; G T CORI
Journal:  J Biol Chem       Date:  1952-12       Impact factor: 5.157
View more
  18 in total

1.  Portal diversion. Treatment for glycogen storage disease and hyperlipemia.

Authors:  T E Starzl; C W Putnam
Journal:  JAMA       Date:  1975-09-01       Impact factor: 56.272

2.  The mother lode of liver transplantation, with particular reference to our new journal.

Authors:  T E Starzl
Journal:  Liver Transpl Surg       Date:  1998-01

3.  The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood.

Authors:  T E Starzl; A Francavilla; C G Halgrimson; F R Francavilla; K A Porter; T H Brown; C W Putnam
Journal:  Surg Gynecol Obstet       Date:  1973-08

4.  Portal diversion in glycogen storage disease.

Authors:  T E Starzl; B I Brown; H Blanchard; L Brettschneider
Journal:  Surgery       Date:  1969-03       Impact factor: 3.982

5.  The effect of partial portacaval transposition on the canine liver.

Authors:  T L Marchioro; K A Porter; B I Brown; J B Otte; T E Starzl
Journal:  Surgery       Date:  1967-05       Impact factor: 3.982

6.  Portal diversion for the treatment of glycogen storage disease in humans.

Authors:  T E Starzl; C W Putnam; K A Porter; C G Halgrimson; J Corman; B I Brown; R W Gotlin; D O Rodgerson; H L Greene
Journal:  Ann Surg       Date:  1973-10       Impact factor: 12.969

Review 7.  Progress in homotransplantation of the liver.

Authors:  T E Starzl; T L Marchioro; K A Porter
Journal:  Adv Surg       Date:  1966

8.  Glycogen storage disease type IV, amylopectinosis.

Authors:  B Levin; E A Burgess; P E Mortimer
Journal:  Arch Dis Child       Date:  1968-10       Impact factor: 3.791

9.  Glycogen storage disease treated by portacaval transposition.

Authors:  A G Ridell; R P Davies
Journal:  Proc R Soc Med       Date:  1966-06

10.  Blood flow during obstruction to the venous effect of portacaval transposition on hepatic outflow from the canine liver.

Authors:  P R Baker; R Shields
Journal:  Ann Surg       Date:  1974-07       Impact factor: 12.969
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.